MoonLake Immunotherapeutics MLTX
12.62 USD +1.09 (+9.45%)
At closeNov 10, 2026, 4:08 AM EST
12.61 -0.01 -0.08%
Pre-market · Nov 10, 4:08 AM ET
11.59 Day range 12.91
9.46 52-week range 23.29
- YTD
- -4.25%
- 1 year
- +18.72%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -244.83M | -143.09M | -54.12M | -65.06M | -53.58M | |
| -230.32M | -121.24M | -44.08M | -64.51M | -53.64M | |
| -3.53 | -1.89 | -0.73 | -1.70 | -230.15 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 334.52M | 180.43M | 451.17M | 39.51M | 8.04M | |
| 424.43M | 477.93M | 526.54M | 76.84M | 9.68M | |
| 119.95M | 24.54M | 13.05M | 8.08M | 21.33M | |
| 75.71M | 2.83M | 3.70M | 282.58K | 15.00M | |
| 304.48M | 446.82M | 495.68M | 48.90M | -11.65M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -196.01M | -116.59M | -42.78M | -55.89M | -35.18M | |
| 202.99M | -205.60M | -25.18M | -32.34M | -50.71K | |
| 146.00M | 51.31M | 479.70M | 119.69M | 43.26M | |
| -35.00K | -520.00K | -284.00K | -16.01K | -50.71K | |
| 154.09M | -270.74M | 411.66M | 31.47M | 8.04M |